Skip to content

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03712891
Enrollment
178
Registered
2018-10-19
Start date
2018-10-25
Completion date
2023-08-16
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PACU Length of Stay, Patient Satisfaction, Postoperative Nausea, Postoperative Vomiting

Keywords

PACU length of stay, coffee

Brief summary

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Detailed description

Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

Interventions

DIETARY_SUPPLEMENTCoffee

Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)

Sponsors

TriHealth Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. 18 years old or older 2. Admitted to Bethesda North Minimally Invasive Surgery Center 3. Reports to consume at least one cup of coffee a day for at least 5 days in a week

Exclusion criteria

1. History of PONV 2. Pre-existing cardiac arrhythmias 3. History of seizure disorder 4. Pregnant

Design outcomes

Primary

MeasureTime frameDescription
PACU Length of Stay6 hoursPost-anesthesia Care Unit length of stay

Countries

United States

Participant flow

Participants by arm

ArmCount
Patients Receiving Coffee Postoperatively
Patients who self-identify as coffee drinkers and receive coffee postoperatively Coffee: Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)
89
Patients Not Receiving Coffee Postoperatively
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively
89
Total178

Baseline characteristics

CharacteristicPatients Not Receiving Coffee PostoperativelyTotalPatients Receiving Coffee Postoperatively
Age, Customized
18 years or older
89 Participants178 Participants89 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
89 participants178 participants89 participants
Sex/Gender, Customized
Did not collect
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 890 / 89
other
Total, other adverse events
0 / 890 / 89
serious
Total, serious adverse events
0 / 890 / 89

Outcome results

Primary

PACU Length of Stay

Post-anesthesia Care Unit length of stay

Time frame: 6 hours

ArmMeasureValue (MEAN)Dispersion
Patients Receiving Coffee PostoperativelyPACU Length of Stay82 minutesStandard Error 5.13
Patients Not Receiving Coffee PostoperativelyPACU Length of Stay76 minutesStandard Error 5.13
p-value: 0.12t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026